Insights, attitudes, and perceptions about asthma and its treatment

a multinational survey of patients from Europe and Canada

Joaquin Sastre, Leonardo M. Fabbri, David Price, Hans Ulrich Wahn, Jean Bousquet, James E. Fish, Kevin Murphy, Malcolm R. Sears

Research output: Contribution to journalArticle

15 Citations (Scopus)
5 Downloads (Pure)

Abstract

BACKGROUND: Asthma surveys completed within the past 10 years in the Americas and the Asia-Pacific region have shown significant underassessment of asthma severity in addition to undertreatment of asthma and have suggested the need to improve long-term asthma management. In this study, we examined the frequency of asthma symptoms and severe episodes, patients' perceived asthma control, and use of asthma medications in Europe and Canada.

METHODS: The Asthma Insight and Management survey (54 questions) was conducted in Europe (Germany, Italy, Spain and the United Kingdom) and Canada from June 14 through July 28, 2010. Telephone interviews were conducted with randomly screened patients or parents of adolescents (aged 12-17 years) with asthma; patients younger than 12 years of age were excluded from the survey. Responses were reported separately for each country and in total for all five countries.

RESULTS: Seventy-five thousand three hundered thirty-five households were screened, and 2003 patients were interviewed. The survey respondents represented a wide range of severity. Overall, 26 % of patients reported symptoms daily or most days over the past 4 weeks, but most patients (81 %) perceived their asthma to be well or completely controlled. Over the past year, 41 % of patients had episodes of frequent/severe symptoms, and 50 % reported acute treatment (e.g. hospitalization, emergency visit, unscheduled physician visit) for asthma. Across countries, 52 % of patients reported taking controller medication every day over the past year, 27 % reported not taking any controller medication, and 14 % reported stopping controller treatment for 3 months or longer the last time they stopped. Many patients considered asthma well controlled if each year they had only two urgent doctor visits (50 %), three or four exacerbations (60 %), and/or one emergency room visit (41 %).

DISCUSSION: This is the largest survey of patients with asthma in Europe and Canada in more than a decade.

CONCLUSION: In 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management. Use of controller medications was substantially less than recommended in treatment guidelines.

Original languageEnglish
Article number13
Pages (from-to)1-12
Number of pages12
JournalWorld Allergy Organization Journal
Volume9
DOIs
Publication statusPublished - 4 May 2016

Fingerprint

Canada
Asthma
Therapeutics
Surveys and Questionnaires
Spain
Italy
Germany
Hospital Emergency Service
Hospitalization
Emergencies
Parents
Guidelines
Interviews

Keywords

  • Asthma
  • Canada
  • Controller medications
  • Europe
  • Management
  • Survey
  • Symptoms

Cite this

Insights, attitudes, and perceptions about asthma and its treatment : a multinational survey of patients from Europe and Canada. / Sastre, Joaquin; Fabbri, Leonardo M.; Price, David; Wahn, Hans Ulrich; Bousquet, Jean; Fish, James E.; Murphy, Kevin; Sears, Malcolm R.

In: World Allergy Organization Journal, Vol. 9, 13, 04.05.2016, p. 1-12.

Research output: Contribution to journalArticle

Sastre, Joaquin ; Fabbri, Leonardo M. ; Price, David ; Wahn, Hans Ulrich ; Bousquet, Jean ; Fish, James E. ; Murphy, Kevin ; Sears, Malcolm R. / Insights, attitudes, and perceptions about asthma and its treatment : a multinational survey of patients from Europe and Canada. In: World Allergy Organization Journal. 2016 ; Vol. 9. pp. 1-12.
@article{a7f9873c3226462aad96a88d7137e29d,
title = "Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada",
abstract = "BACKGROUND: Asthma surveys completed within the past 10 years in the Americas and the Asia-Pacific region have shown significant underassessment of asthma severity in addition to undertreatment of asthma and have suggested the need to improve long-term asthma management. In this study, we examined the frequency of asthma symptoms and severe episodes, patients' perceived asthma control, and use of asthma medications in Europe and Canada.METHODS: The Asthma Insight and Management survey (54 questions) was conducted in Europe (Germany, Italy, Spain and the United Kingdom) and Canada from June 14 through July 28, 2010. Telephone interviews were conducted with randomly screened patients or parents of adolescents (aged 12-17 years) with asthma; patients younger than 12 years of age were excluded from the survey. Responses were reported separately for each country and in total for all five countries.RESULTS: Seventy-five thousand three hundered thirty-five households were screened, and 2003 patients were interviewed. The survey respondents represented a wide range of severity. Overall, 26 {\%} of patients reported symptoms daily or most days over the past 4 weeks, but most patients (81 {\%}) perceived their asthma to be well or completely controlled. Over the past year, 41 {\%} of patients had episodes of frequent/severe symptoms, and 50 {\%} reported acute treatment (e.g. hospitalization, emergency visit, unscheduled physician visit) for asthma. Across countries, 52 {\%} of patients reported taking controller medication every day over the past year, 27 {\%} reported not taking any controller medication, and 14 {\%} reported stopping controller treatment for 3 months or longer the last time they stopped. Many patients considered asthma well controlled if each year they had only two urgent doctor visits (50 {\%}), three or four exacerbations (60 {\%}), and/or one emergency room visit (41 {\%}).DISCUSSION: This is the largest survey of patients with asthma in Europe and Canada in more than a decade.CONCLUSION: In 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management. Use of controller medications was substantially less than recommended in treatment guidelines.",
keywords = "Asthma , Canada, Controller medications, Europe, Management, Survey, Symptoms",
author = "Joaquin Sastre and Fabbri, {Leonardo M.} and David Price and Wahn, {Hans Ulrich} and Jean Bousquet and Fish, {James E.} and Kevin Murphy and Sears, {Malcolm R.}",
note = "Acknowledgments Editorial assistance was provided by Ken Kauffman and Patricia Abramo, Adelphi Communications, New York, NY. This assistance was funded by Merck & Co., Inc.",
year = "2016",
month = "5",
day = "4",
doi = "10.1186/s40413-016-0105-4",
language = "English",
volume = "9",
pages = "1--12",
journal = "World Allergy Organization Journal",
issn = "1939-4551",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Insights, attitudes, and perceptions about asthma and its treatment

T2 - a multinational survey of patients from Europe and Canada

AU - Sastre, Joaquin

AU - Fabbri, Leonardo M.

AU - Price, David

AU - Wahn, Hans Ulrich

AU - Bousquet, Jean

AU - Fish, James E.

AU - Murphy, Kevin

AU - Sears, Malcolm R.

N1 - Acknowledgments Editorial assistance was provided by Ken Kauffman and Patricia Abramo, Adelphi Communications, New York, NY. This assistance was funded by Merck & Co., Inc.

PY - 2016/5/4

Y1 - 2016/5/4

N2 - BACKGROUND: Asthma surveys completed within the past 10 years in the Americas and the Asia-Pacific region have shown significant underassessment of asthma severity in addition to undertreatment of asthma and have suggested the need to improve long-term asthma management. In this study, we examined the frequency of asthma symptoms and severe episodes, patients' perceived asthma control, and use of asthma medications in Europe and Canada.METHODS: The Asthma Insight and Management survey (54 questions) was conducted in Europe (Germany, Italy, Spain and the United Kingdom) and Canada from June 14 through July 28, 2010. Telephone interviews were conducted with randomly screened patients or parents of adolescents (aged 12-17 years) with asthma; patients younger than 12 years of age were excluded from the survey. Responses were reported separately for each country and in total for all five countries.RESULTS: Seventy-five thousand three hundered thirty-five households were screened, and 2003 patients were interviewed. The survey respondents represented a wide range of severity. Overall, 26 % of patients reported symptoms daily or most days over the past 4 weeks, but most patients (81 %) perceived their asthma to be well or completely controlled. Over the past year, 41 % of patients had episodes of frequent/severe symptoms, and 50 % reported acute treatment (e.g. hospitalization, emergency visit, unscheduled physician visit) for asthma. Across countries, 52 % of patients reported taking controller medication every day over the past year, 27 % reported not taking any controller medication, and 14 % reported stopping controller treatment for 3 months or longer the last time they stopped. Many patients considered asthma well controlled if each year they had only two urgent doctor visits (50 %), three or four exacerbations (60 %), and/or one emergency room visit (41 %).DISCUSSION: This is the largest survey of patients with asthma in Europe and Canada in more than a decade.CONCLUSION: In 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management. Use of controller medications was substantially less than recommended in treatment guidelines.

AB - BACKGROUND: Asthma surveys completed within the past 10 years in the Americas and the Asia-Pacific region have shown significant underassessment of asthma severity in addition to undertreatment of asthma and have suggested the need to improve long-term asthma management. In this study, we examined the frequency of asthma symptoms and severe episodes, patients' perceived asthma control, and use of asthma medications in Europe and Canada.METHODS: The Asthma Insight and Management survey (54 questions) was conducted in Europe (Germany, Italy, Spain and the United Kingdom) and Canada from June 14 through July 28, 2010. Telephone interviews were conducted with randomly screened patients or parents of adolescents (aged 12-17 years) with asthma; patients younger than 12 years of age were excluded from the survey. Responses were reported separately for each country and in total for all five countries.RESULTS: Seventy-five thousand three hundered thirty-five households were screened, and 2003 patients were interviewed. The survey respondents represented a wide range of severity. Overall, 26 % of patients reported symptoms daily or most days over the past 4 weeks, but most patients (81 %) perceived their asthma to be well or completely controlled. Over the past year, 41 % of patients had episodes of frequent/severe symptoms, and 50 % reported acute treatment (e.g. hospitalization, emergency visit, unscheduled physician visit) for asthma. Across countries, 52 % of patients reported taking controller medication every day over the past year, 27 % reported not taking any controller medication, and 14 % reported stopping controller treatment for 3 months or longer the last time they stopped. Many patients considered asthma well controlled if each year they had only two urgent doctor visits (50 %), three or four exacerbations (60 %), and/or one emergency room visit (41 %).DISCUSSION: This is the largest survey of patients with asthma in Europe and Canada in more than a decade.CONCLUSION: In 2010, many surveyed patients in Europe and Canada reported features indicating uncontrolled asthma, yet the majority believed they were well controlled, indicating that they had low expectations of long-term asthma management. Use of controller medications was substantially less than recommended in treatment guidelines.

KW - Asthma

KW - Canada

KW - Controller medications

KW - Europe

KW - Management

KW - Survey

KW - Symptoms

U2 - 10.1186/s40413-016-0105-4

DO - 10.1186/s40413-016-0105-4

M3 - Article

VL - 9

SP - 1

EP - 12

JO - World Allergy Organization Journal

JF - World Allergy Organization Journal

SN - 1939-4551

M1 - 13

ER -